The COVID-19 Vaccine and Pregnant Minority Women in the US: Implications for Improving Vaccine Confidence and Uptake

• Published in: Vaccines (Basel) Vol. 10; no. 12; p. 2122
• Main Authors: Alcendor, Donald J., Matthews-Juarez, Patricia, Smoot, Duane, Hildreth, James E. K., Tabatabai, Mohammad, Wilus, Derek, Brown, Katherine Y., Juarez, Paul D.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.12.2022; MDPI
• Subjects: Care and treatment; Community involvement; Community participation; COVID-19; COVID-19 vaccines; Demographic aspects; Diphtheria; DPT vaccine; Drug approval; Fatalities; Influenza; Medical societies; minorities; Mortality; mRNA; Obstetrics; Pandemics; Pertussis; Pharmaceutical industry; Pregnancy; Pregnancy complications; Pregnant women; Public health; Race factors; Review; RNA; Safety and security measures; Tdap; Tetanus; Tetanus antitoxin; Vaccination; vaccinations; Vaccines; Whooping-cough; Womens health; United States; United States > US; COVID-19; influenza; vaccine hesitancy; vaccinations; minorities; pregnancy; Tdap; women
• ISSN: 2076-393X; 2076-393X
• DOI: 10.3390/vaccines10122122

The American College of Obstetricians and Gynecologists (AGOG) recommends the FDA-approved Pfizer and Moderna mRNA COVID-19 vaccines and boosters for all eligible pregnant women in the US. However, COVID-19 vaccine confidence and uptake among pregnant minority women have been poor. While the underlying reasons are unclear, they are likely to be associated with myths and misinformation about the vaccines. Direct and indirect factors that deter minority mothers in the US from receiving the mRNA COVID-19 vaccines require further investigation. Here, we examine the historical perspectives on vaccinations during pregnancy. We will examine the following aspects: (1) the influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccinations during pregnancy; (2) the exclusion of pregnant and lactating women from COVID-19 vaccine trials; (3) COVID-19 vaccine safety during pregnancy, obstetric complications associated with symptomatic COVID-19 during pregnancy, COVID-19 vaccine hesitancy among pregnant minority women, and racial disparities experienced by pregnant minority women due to the COVID-19 pandemic as well as their potential impact on pregnancy care; and (4) strategies to improve COVID-19 vaccine confidence and uptake among pregnant minority women in the US. COVID-19 vaccine hesitancy among minority mothers can be mitigated by community engagement efforts that focus on COVID-19 vaccine education, awareness campaigns by trusted entities, and COVID-19-appropriate perinatal counseling aimed to improve COVID-19 vaccine confidence and uptake.